Levels of mTOR and its downstream targets 4E‐BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain
Open Access
- 3 August 2005
- journal article
- Published by Wiley in The FEBS Journal
- Vol. 272 (16) , 4211-4220
- https://doi.org/10.1111/j.1742-4658.2005.04833.x
Abstract
The pathogenesis of formation of neurofibrillary tangles (NFTs) in Alzheimer's disease (AD) brains is unknown. One of the possibilities might be that translation of tau mRNA is aberrantly regulated in AD brains. In the current study, levels of various translation control elements including total and phosphorylated (p) forms of mammalian target of rapamycin (mTOR), eukaryotic initiation factor 4E binding protein 1 (4E‐BP1), eukaryotic elongation factor 2 (eEF2), and eEF2 kinase were investigated in relationship with tau in homogenates of the medial temporal cortex from 20 AD and 10 control brains. We found that levels of p‐mTOR (Ser2481), and p‐4E‐BP1 (Thr70 and Ser65) dramatically increase in AD, and are positively significantly correlated with total tau and p‐tau. Levels of p‐eEF2K were significantly increased, and total eEF2 significantly decreased in AD, when compared to controls. The changes of p‐mTOR (2481), p‐4E‐BP1, and p‐eEF2 were immunohistochemically confirmed to be in neurons of AD brains. This suggested that there are obvious abnormalities of elements related with translation control in AD brain and their aberrant changes may up‐regulate the translation of tau mRNA, contributing to hyperphosphorylated tau accumulation in NFT‐bearing neurons.Keywords
This publication has 27 references indexed in Scilit:
- Expression of tau mRNA and soluble tau isoforms in affected and non‐affected brain areas in Alzheimer's diseaseFEBS Letters, 2004
- Up-Regulation of Phosphorylated/Activated p70 S6 Kinase and Its Relationship to Neurofibrillary Pathology in Alzheimer's DiseaseThe American Journal of Pathology, 2003
- The Insulin-Induced Signalling Pathway Leading to S6 and Initiation Factor 4E Binding Protein 1 Phosphorylation Bifurcates at a Rapamycin-Sensitive Point Immediately Upstream of p70s6kMolecular and Cellular Biology, 1997
- Functional studies of Alzheimer's disease tau proteinJournal of Neuroscience, 1993
- Brain Levels of Microtubule‐Associated Protein τ Are Elevated in Alzheimer's Disease: A Radioimmuno‐Slot‐Blot Assay for Nanograms of the ProteinJournal of Neurochemistry, 1992
- In situ hybridization of calcium/calmodulin dependent protein kinase II and tau mRNAs: species differences and relative preservation in Alzheimer's diseaseMolecular Brain Research, 1992
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)Neurology, 1991
- Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.Proceedings of the National Academy of Sciences, 1986
- Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease.Proceedings of the National Academy of Sciences, 1986
- One of the Antigenic Determinants of Paired Helical Filaments Is Related to Tau Protein1The Journal of Biochemistry, 1986